- Q4 2023 Vaxcyte Inc Earnings Call TranscriptFeb 27, 2024$81.05 (+2.63%)Earnings
- Vaxcyte Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Vaxcyte Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Vaxcyte Inc VAX-24 Phase 2 65+ Adult Study Results Call TranscriptApr 17, 2023
- Q4 2022 Vaxcyte Inc Earnings Call TranscriptFeb 27, 2023$42.3 (+1.44%)Earnings
- Vaxcyte Inc VAX-24 Phase 1/2 Proof-of-Concept Study Topline Data Call TranscriptOct 24, 2022
- Vaxcyte Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Vaxcyte Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
- Q4 2021 Vaxcyte Inc Earnings Call TranscriptFeb 28, 2022$23.17 (+2.52%)Earnings
- Vaxcyte Inc at Guggenheim Vaccine and Infectious Disease Conference (Virtual) TranscriptOct 05, 2021
- Vaxcyte Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q4 2020 Vaxcyte Inc Earnings Call TranscriptMar 29, 2021Earnings
Vaxcyte Inc at Bank of America Healthcare Conference Transcript
All right, everybody. Thanks for joining us for our next company presenter at the Bank of America Annual Healthcare Conference in Las Vegas. My name is Jason Gerberry, I'm one of the biotech analyst at BofA, and I'm pleased to be introducing our next company presenter, Vaxcyte. We've got Grant Pickering, CEO; and we've got Jim Wassil, COO, with us on stage. Gentlemen, both, thanks for joining us.
Thank you for having us.
So maybe, I don't know, Grant, if you want to set the stage at all for Vaxcyte. Who you guys are as a company. Set the stage in terms of pneumococcal vaccination as a marketplace. I don't think that it needs a lot of context. It's a very large market at $7 billion global revenue, and forecasted to go, I think, upwards of like $8 billion to $10 billion in the future
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)